We found that caspase-4 positive NSCLC patients had a differential lipidomic signature in that both the palmitic and the malonic acid were higher present in the tumor mass of caspase-4 positive rather than negative NSCLC patients. The gene discussed is CASP4; the disease is non-small cell lung carcinoma.